Buscar
Mostrando ítems 1-10 de 141
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D-2 receptor affinity
(Sage Publications Ltd, 2004-03-01)
Evidence suggests atypical antipsychotic treatment is associated with a Lower incidence of tardive dyskinesia (TD) than typical antipsychotic drugs, and is a potential antidyskinetic treatment. We present the case of a ...
Priapism associated with risperidone use. Report of one case
(Sociedad Médica de Santiago, 2012)
The use of drugs with α-adrenergic antagonistic effect is one of the most prominent etiologies of priapism. We report a 32-year-old schizophrenic male in treatment with risperidone who consulted in the emergency room for ...
All-cause mortality in older adults with affective disorders and dementia under treatment with antipsychotic drugs: A matched-cohort study
(Elsevier Ireland, 2018-07)
We aimed to compare the mortality risk between patients with affective disorders and dementia under treatment with antipsychotics. To do this, a matched-cohort study based on an electronic database of a tertiary teaching ...
Metabolic syndrome and antipsychotics: The role of mitochondrial fission/fusion imbalance
(Frontiers Media SA, 2018)
Second-generation antipsychotics (SGAs) are known to increase cardiovascular risk through several physiological mechanisms, including insulin resistance, hepatic steatosis, hyperphagia, and accelerated weight gain. There ...
Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews
(Associação Paulista de Medicina - APM, 2010-05-01)
CONTEXT AND OBJECTIVE: According to some cohort studies, the prevalence of refractory schizophrenia (RS) is 20-40%. Our aim was to evaluate the effectiveness and safety of aripiprazole, paliperidone, quetiapine and risperidone ...
Diabetes mellitus inducida por olanzapina: Caso clínico
(Sociedad Médica de Santiago, 2001)
The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study
(Physicians Postgraduate Press, 2019-08)
BACKGROUND: Venous thromboembolism (VTE) represents a major cause of morbidity and mortality worldwide. Antipsychotic treatment is associated with an increased risk of thromboembolic disease, an effect that seems to be ...